BIRC5 and neuroblastoma: Next, the Kocak and SEQC-RPM datasets revealed that high expression of survivin was associated with poor overall survival of neuroblastoma patients in Stage 2 and 3, but not in Stage 1, 4, and 4s (Figure 5E,F) [45].